SSCI Offers Benchmarks As Gatekeepers For Supplements To Reach Retail Shelves
Executive Summary
FDA’s GMP final rule set uniform standards to ensure quality throughout manufacturing, packaging, labeling and holding of supplements, but Supplement Safety and Compliance Initiative says manufacturing practices continue to vary widely across the industry and the agency cannot inspect every facility. “FDA can’t solve all our problems. I don’t know if FDA knows the number of facilities it needs to inspect to ensure consumer confidence," says Daniel Fabricant, president of SSCI member NPA.
You may also be interested in...
Medical Association's Diagnosis Of US Supplement Market Has Industry Asking For Second Opinion
AMA decides “to call for more stringent federal regulation of supplements—including increased oversight of manufacturing, marketing, product labeling, and adverse event reporting.” But NPA CEO Daniel Fabricant says supplements account for a fraction of the problems linked to drugs approved for sale in the US. "We don’t have a vitamin C crisis in America, we do have an opioid crisis."
US Process Modeled On OTC Review Could Improve Supplement Health Claim Requests’ Chances
Claims supplements could be stronger, says a veteran food and supplement industry attorney, if FDA would give appropriate credit to the scientific evidence that firms are providing with their requests to use unqualified health claims.
FDA Slacking In NDI Notification Enforcement; COVID-19 'Is Not An Excuse’ – NPA
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.